Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 26.36

+2.4%

10:53 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ibexx who wrote (366)	6/19/1998 4:50:00 PM
From: Anthony Wong	of 1722

Ibexx, I agree that it's not a financial disaster. Expect Pfizer to get approval eventually, maybe the date would be pushed forward 6 months to one year. The market, however, is not to be sneezed at. LLY's Zyprexa (approved in late 1996) had $730 million in 1997 sales, and JNJ's Risperdal's 1997 sales (approved 4 years ago) have estimated 1997 sales of more than $840 million. Schizophrenic patients used to be delinquent in taking the drugs prescribed to them because of the drugs side effects. Pfizer may be able to take some of the market share away from LLY and JNJ. This weakness would be short-lived. Viagra would be approved in Europe in September and that should improve the sales figures for the last quarter, and their new antibiotic drug is also doing well.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next